| Literature DB >> 31632752 |
William Lightle1, Daoud Daoud1, Gabriel Loor1.
Abstract
Ex vivo lung perfusion (EVLP) represents a potentially important advancement in the preservation of donor lungs prior to transplantation. Portable EVLP or "Breathing Lung Transplantation" with the Organ Care System (OCS) Lung combines the fundamental components of EVLP with portability, thus reducing the total ischemic burden. The Food and Drug Administration (FDA) approved OCS for perfusion of standard donor lungs prior to transplant in 2018. The current review discusses the available literature on the clinical outcomes of OCS Lung as well as translational data. 2019 Journal of Thoracic Disease. All rights reserved.Entities:
Keywords: Ex vivo lung perfusion (EVLP); Organ Care System (OCS); donor lung; lung transplantation
Year: 2019 PMID: 31632752 PMCID: PMC6783715 DOI: 10.21037/jtd.2019.03.32
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895